Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4B pseudogene 4 (EIF4BP4) is a genomically encoded pseudogene related to the functional initiation factor EIF4B. Unlike EIF4B, which acts as an RNA-binding protein stimulating the helicase activity of eIF4A to promote mRNA unwinding and translation initiation, EIF4BP4 does not produce a functional protein and is not involved in translation or cellular signaling[4]. Pseudogenes like EIF4BP4 may be transcriptionally silent or occasionally transcribed as noncoding RNA, but they lack any direct protein-coding function or established role in disease biology or pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4B pseudogene 4 (EIF4BP4).